Orexo

About:

Orexo is a pharmaceutical company developing improved treatments using proprietary drug delivery technology.

Top Investors: Novo Holdings, Sofinnova Investments, HealthCap, Apex Venture Partners, Auriga Partners

Description:

Orexo develops improved specialty pharmaceuticals and treatments for new areas of use – at a lower cost, in a shorter period of time and at a lower risk – by combining known substances with patented proprietary technologies.

Total Funding Amount:

$122M

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

Uppsala, Uppsala Lan, Sweden

Founded Date:

1995-01-01

Contact Email:

info(AT)orexo.com

Founders:

Anders Pettersson, Christer Nyström, Thomas Lundqvist

Number of Employees:

51-100

Last Funding Date:

2024-03-13

IPO Status:

Public

Industries: